Published in Biochem Biophys Res Commun on September 12, 2006
Norovirus regulation of the innate immune response and apoptosis occurs via the product of the alternative open reading frame 4. PLoS Pathog (2011) 1.61
Poly(C)-binding proteins as transcriptional regulators of gene expression. Biochem Biophys Res Commun (2009) 1.20
A proteomics approach for identification of single strand DNA-binding proteins involved in transcriptional regulation of mouse mu opioid receptor gene. Mol Cell Proteomics (2008) 0.99
Feline calicivirus p32, p39 and p30 proteins localize to the endoplasmic reticulum to initiate replication complex formation. J Gen Virol (2009) 0.91
Cellular poly(c) binding proteins 1 and 2 interact with porcine reproductive and respiratory syndrome virus nonstructural protein 1β and support viral replication. J Virol (2011) 0.85
RACK1 identified as the PCBP1-interacting protein with a novel functional role on the regulation of human MOR gene expression. J Neurochem (2012) 0.79
Norovirus genome circularization and efficient replication are facilitated by binding of PCBP2 and hnRNP A1. J Virol (2013) 0.78
Poly(C)-binding protein 1, a novel N(pro)-interacting protein involved in classical swine fever virus growth. J Virol (2012) 0.78
Morphine drives internal ribosome entry site-mediated hnRNP K translation in neurons through opioid receptor-dependent signaling. Nucleic Acids Res (2014) 0.77
Protein expression of sensory and motor nerves: Two-dimensional gel electrophoresis and mass spectrometry. Neural Regen Res (2012) 0.75
Sequence requirements for nuclear location of simian virus 40 large-T antigen. Nature (1984) 10.52
Two interdependent basic domains in nucleoplasmin nuclear targeting sequence: identification of a class of bipartite nuclear targeting sequence. Cell (1991) 9.96
Dynamics of DNA replication factories in living cells. J Cell Biol (2000) 4.93
A nuclear localization domain in the hnRNP A1 protein. J Cell Biol (1995) 4.51
mRNA silencing in erythroid differentiation: hnRNP K and hnRNP E1 regulate 15-lipoxygenase translation from the 3' end. Cell (1997) 4.03
The poly(C)-binding proteins: a multiplicity of functions and a search for mechanisms. RNA (2002) 3.62
The K nuclear shuttling domain: a novel signal for nuclear import and nuclear export in the hnRNP K protein. EMBO J (1997) 3.46
Requirement of poly(rC) binding protein 2 for translation of poliovirus RNA. J Virol (1997) 3.40
Exploring the opioid system by gene knockout. Prog Neurobiol (2002) 2.69
Targeting of Ikaros to pericentromeric heterochromatin by direct DNA binding. Genes Dev (2000) 2.55
Heterogeneous nuclear ribonucleoprotein K is a transcription factor. Mol Cell Biol (1996) 2.43
Silencing is golden: negative regulation in the control of neuronal gene transcription. Curr Opin Neurobiol (1995) 2.21
Erythroid cell-specific mRNA stability elements in the alpha 2-globin 3' nontranslated region. Mol Cell Biol (1995) 2.04
c-Src-mediated phosphorylation of hnRNP K drives translational activation of specifically silenced mRNAs. Mol Cell Biol (2002) 1.98
Four highly stable eukaryotic mRNAs assemble 3' untranslated region RNA-protein complexes sharing cis and trans components. Proc Natl Acad Sci U S A (1997) 1.97
Cell cycle-dependent phosphorylation of the ATRX protein correlates with changes in nuclear matrix and chromatin association. Hum Mol Genet (2000) 1.59
Identification of mRNAs associated with alphaCP2-containing RNP complexes. Mol Cell Biol (2003) 1.49
Opioid tolerance-in search of the holy grail. Cell (2002) 1.46
Carboxyl-terminal splicing of the rat mu opioid receptor modulates agonist-mediated internalization and receptor resensitization. J Biol Chem (1998) 1.43
Generation of the mu opioid receptor (MOR-1) protein by three new splice variants of the Oprm gene. Proc Natl Acad Sci U S A (2001) 1.43
Expression of two variants of the human mu opioid receptor mRNA in SK-N-SH cells and human brain. FEBS Lett (1994) 1.39
Nuclear localization of IkappaB alpha is mediated by the second ankyrin repeat: the IkappaB alpha ankyrin repeats define a novel class of cis-acting nuclear import sequences. Mol Cell Biol (1998) 1.37
Genomic structure analysis of promoter sequence of a mouse mu opioid receptor gene. Proc Natl Acad Sci U S A (1994) 1.34
Opioids, reward and addiction: An encounter of biology, psychology, and medicine. Pharmacol Rev (1999) 1.26
Identification of the SRC pyrimidine-binding protein (SPy) as hnRNP K: implications in the regulation of SRC1A transcription. Nucleic Acids Res (2003) 1.26
Insights into the receptor transcription and signaling: implications in opioid tolerance and dependence. Neuropharmacology (2004) 1.22
A novel set of nuclear localization signals determine distributions of the alphaCP RNA-binding proteins. Mol Cell Biol (2003) 1.16
Neuron-restrictive silencer factor (NRSF) functions as a repressor in neuronal cells to regulate the mu opioid receptor gene. J Biol Chem (2004) 1.13
Poly(C) binding protein family is a transcription factor in mu-opioid receptor gene expression. Mol Pharmacol (2005) 1.11
AIRE encodes a nuclear protein co-localizing with cytoskeletal filaments: altered sub-cellular distribution of mutants lacking the PHD zinc fingers. Hum Mol Genet (1999) 1.11
Transcriptional regulation of mouse mu-opioid receptor gene. J Biol Chem (1998) 1.06
Heterogeneous nuclear ribonucleoprotein (hnRNP) binding to hormone response elements: a cause of vitamin D resistance. Proc Natl Acad Sci U S A (2003) 1.06
Dual promoters of mouse mu-opioid receptor gene. Biochem Biophys Res Commun (1997) 1.05
A tripartite nuclear localization signal in the PDZ-domain protein L-periaxin. J Biol Chem (2000) 1.05
Single-stranded DNA-binding complex involved in transcriptional regulation of mouse mu-opioid receptor gene. J Biol Chem (2001) 1.04
Identification and characterization of a novel promoter of the mouse mu opioid receptor gene (Oprm) that generates eight splice variants. Gene (2002) 1.01
Poly C binding protein, a single-stranded DNA binding protein, regulates mouse mu-opioid receptor gene expression. J Neurochem (2005) 1.00
Cloning and characterization of the promoter region of the mouse mu opioid receptor gene. Brain Res (1995) 0.95
Molecular basis underlying the poly C binding protein 1 as a regulator of the proximal promoter of mouse mu-opioid receptor gene. Brain Res (2006) 0.93
Differential promoter usage of mouse mu-opioid receptor gene during development. Brain Res Mol Brain Res (2002) 0.92
Interaction between hnRNPA1 and IkappaBalpha is required for maximal activation of NF-kappaB-dependent transcription. Mol Cell Biol (2001) 0.92
Role of an AP-2-like element in transcriptional regulation of mouse mu-opioid receptor gene. Brain Res Mol Brain Res (2003) 0.90
Importin alpha binds to an unusual bipartite nuclear localization signal in the heterogeneous ribonucleoprotein type I. Eur J Biochem (2002) 0.90
Interplay of Sps and poly(C) binding protein 1 on the mu-opioid receptor gene expression. Biochem Biophys Res Commun (2006) 0.88
Mechanisms of nuclear transport and interventions. Adv Drug Deliv Rev (2003) 0.85
Ribosomal RNA transcriptional activation and processing in hamster facial motoneurons: effects of axotomy with or without exposure to testosterone. J Comp Neurol (1998) 0.79
Unidirectional cross-activation of GRPR by MOR1D uncouples itch and analgesia induced by opioids. Cell (2011) 2.13
Beta-arrestin-dependent mu-opioid receptor-activated extracellular signal-regulated kinases (ERKs) Translocate to Nucleus in Contrast to G protein-dependent ERK activation. Mol Pharmacol (2007) 1.56
Agonist-selective signaling is determined by the receptor location within the membrane domains. Proc Natl Acad Sci U S A (2008) 1.36
Axonal mRNA transport and localized translational regulation of kappa-opioid receptor in primary neurons of dorsal root ganglia. Proc Natl Acad Sci U S A (2006) 1.35
Mu-opioid receptors modulate the stability of dendritic spines. Proc Natl Acad Sci U S A (2005) 1.34
Heterodimerization of mu- and delta-opioid receptors occurs at the cell surface only and requires receptor-G protein interactions. J Biol Chem (2005) 1.34
Spinal G-protein-gated potassium channels contribute in a dose-dependent manner to the analgesic effect of mu- and delta- but not kappa-opioids. J Neurosci (2005) 1.33
Inhibition of PI3K/Akt signaling: an emerging paradigm for targeted cancer therapy. Curr Med Chem Anticancer Agents (2005) 1.32
Evidence of endogenous mu opioid receptor regulation by epigenetic control of the promoters. Mol Cell Biol (2007) 1.25
Mu-opioid receptor desensitization: role of receptor phosphorylation, internalization, and representation. J Biol Chem (2003) 1.25
Adenylyl cyclase superactivation induced by long-term treatment with opioid agonist is dependent on receptor localized within lipid rafts and is independent of receptor internalization. Mol Pharmacol (2006) 1.21
Epigenetic programming of mu-opioid receptor gene in mouse brain is regulated by MeCP2 and Brg1 chromatin remodelling factor. J Cell Mol Med (2008) 1.21
Poly(C)-binding proteins as transcriptional regulators of gene expression. Biochem Biophys Res Commun (2009) 1.20
Morphine-induced mu-opioid receptor rapid desensitization is independent of receptor phosphorylation and beta-arrestins. Cell Signal (2008) 1.19
Morphine regulates dopaminergic neuron differentiation via miR-133b. Mol Pharmacol (2010) 1.18
mu-Opioid receptor agonists differentially regulate the expression of miR-190 and NeuroD. Mol Pharmacol (2009) 1.18
Regulation of opioid receptor expression. Curr Opin Pharmacol (2002) 1.16
Agonist-selective signaling of G protein-coupled receptor: mechanisms and implications. IUBMB Life (2010) 1.14
Neuron-restrictive silencer factor (NRSF) functions as a repressor in neuronal cells to regulate the mu opioid receptor gene. J Biol Chem (2004) 1.13
Distinct effects of individual opioids on the morphology of spines depend upon the internalization of mu opioid receptors. Mol Cell Neurosci (2007) 1.12
Rewarding effects of ethanol and cocaine in mu opioid receptor-deficient mice. Naunyn Schmiedebergs Arch Pharmacol (2002) 1.11
Poly(C) binding protein family is a transcription factor in mu-opioid receptor gene expression. Mol Pharmacol (2005) 1.11
Yin Yang 1 phosphorylation contributes to the differential effects of mu-opioid receptor agonists on microRNA-190 expression. J Biol Chem (2010) 1.11
Palmitoylation and membrane cholesterol stabilize μ-opioid receptor homodimerization and G protein coupling. BMC Cell Biol (2012) 1.10
Netrin-1 signaling regulates de novo protein synthesis of kappa opioid receptor by facilitating polysomal partition of its mRNA. J Neurosci (2006) 1.08
Post-transcriptional regulation of opioid receptors in the nervous system. Front Biosci (2004) 1.06
Mouse kappa-opioid receptor mRNA differential transport in neurons. Mol Pharmacol (2003) 1.05
Up-regulation of the mu-opioid receptor gene is mediated through chromatin remodeling and transcriptional factors in differentiated neuronal cells. Mol Pharmacol (2010) 1.04
Long-term morphine treatment decreases the association of mu-opioid receptor (MOR1) mRNA with polysomes through miRNA23b. Mol Pharmacol (2009) 1.04
Evidence of the neuron-restrictive silencer factor (NRSF) interaction with Sp3 and its synergic repression to the mu opioid receptor (MOR) gene. Nucleic Acids Res (2006) 1.04
Copb1-facilitated axonal transport and translation of kappa opioid-receptor mRNA. Proc Natl Acad Sci U S A (2007) 1.03
Transcriptional regulation of mouse mu opioid receptor gene by PU.1. J Biol Chem (2004) 1.03
Novel function of the poly(C)-binding protein alpha CP3 as a transcriptional repressor of the mu opioid receptor gene. FASEB J (2007) 1.03
Agonist-dependent mu-opioid receptor signaling can lead to heterologous desensitization. Cell Signal (2010) 1.03
Mouse mu opioid receptor distal promoter transcriptional regulation by SOX proteins. J Biol Chem (2002) 1.03
Modulations of NeuroD activity contribute to the differential effects of morphine and fentanyl on dendritic spine stability. J Neurosci (2010) 1.02
The immunosuppressive effects of chronic morphine treatment are partially dependent on corticosterone and mediated by the mu-opioid receptor. J Leukoc Biol (2002) 1.02
The opioid ligand binding of human mu-opioid receptor is modulated by novel splice variants of the receptor. Biochem Biophys Res Commun (2006) 1.02
Translational repression of mouse mu opioid receptor expression via leaky scanning. Nucleic Acids Res (2007) 1.00
Modulating micro-opioid receptor phosphorylation switches agonist-dependent signaling as reflected in PKCepsilon activation and dendritic spine stability. J Biol Chem (2011) 1.00
Poly C binding protein, a single-stranded DNA binding protein, regulates mouse mu-opioid receptor gene expression. J Neurochem (2005) 1.00
A proteomics approach for identification of single strand DNA-binding proteins involved in transcriptional regulation of mouse mu opioid receptor gene. Mol Cell Proteomics (2008) 0.99
Increased dopamine D2 receptor binding and enhanced apomorphine-induced locomotor activity in mu-opioid receptor knockout mice. Brain Res Bull (2003) 0.98
Post-transcriptional regulation of mouse mu opioid receptor (MOR1) via its 3' untranslated region: a role for microRNA23b. FASEB J (2008) 0.98
Transcriptional regulation of mouse mu opioid receptor gene: Sp3 isoforms (M1, M2) function as repressors in neuronal cells to regulate the mu opioid receptor gene. Mol Pharmacol (2005) 0.98
Transcriptional and epigenetic regulation of opioid receptor genes: present and future. Annu Rev Pharmacol Toxicol (2011) 0.97
Rescuing the traffic-deficient mutants of rat mu-opioid receptors with hydrophobic ligands. Mol Pharmacol (2003) 0.97
Src phosphorylation of micro-receptor is responsible for the receptor switching from an inhibitory to a stimulatory signal. J Biol Chem (2008) 0.97
MicroRNAs in opioid pharmacology. J Neuroimmune Pharmacol (2011) 0.96
Nuclear factor kappaB signaling in opioid functions and receptor gene expression. J Neuroimmune Pharmacol (2006) 0.95
Morphine negatively regulates interferon-gamma promoter activity in activated murine T cells through two distinct cyclic AMP-dependent pathways. J Biol Chem (2003) 0.95
Retinoic acid-induced chromatin remodeling of mouse kappa opioid receptor gene. J Neurosci (2005) 0.95
mu-Opioid receptor knockout mice are insensitive to methamphetamine-induced behavioral sensitization. J Neurosci Res (2010) 0.95
Phosphorylation of the delta-opioid receptor regulates its beta-arrestins selectivity and subsequent receptor internalization and adenylyl cyclase desensitization. J Biol Chem (2007) 0.94
Short- and long-term regulation of adenylyl cyclase activity by delta-opioid receptor are mediated by Galphai2 in neuroblastoma N2A cells. Mol Pharmacol (2006) 0.94
Effects of trichostatin A on neuronal mu-opioid receptor gene expression. Brain Res (2008) 0.93
Geldanamycin inhibits hemorrhage-induced increases in caspase-3 activity: role of inducible nitric oxide synthase. J Appl Physiol (1985) (2007) 0.93
Molecular basis underlying the poly C binding protein 1 as a regulator of the proximal promoter of mouse mu-opioid receptor gene. Brain Res (2006) 0.93
Chronic morphine treatment differentiates T helper cells to Th2 effector cells by modulating transcription factors GATA 3 and T-bet. J Neuroimmunol (2004) 0.92
Differential promoter usage of mouse mu-opioid receptor gene during development. Brain Res Mol Brain Res (2002) 0.92
The other side of the opioid story: modulation of cell growth and survival signaling. Curr Med Chem (2008) 0.92
MicroRNA 339 down-regulates μ-opioid receptor at the post-transcriptional level in response to opioid treatment. FASEB J (2012) 0.92
DPDPE-UK14,304 synergy is retained in mu opioid receptor knockout mice. Pain (2003) 0.91
In vivo activation of a mutant mu-opioid receptor by naltrexone produces a potent analgesic effect but no tolerance: role of mu-receptor activation and delta-receptor blockade in morphine tolerance. J Neurosci (2005) 0.90
GRIN1 regulates micro-opioid receptor activities by tethering the receptor and G protein in the lipid raft. J Biol Chem (2009) 0.90
Role of an AP-2-like element in transcriptional regulation of mouse mu-opioid receptor gene. Brain Res Mol Brain Res (2003) 0.90
Antagonist efficacy in MORS196L mutant is affected by the interaction between transmembrane domains of the opioid receptor. J Pharmacol Exp Ther (2004) 0.89
Non-Coding RNAs Regulating Morphine Function: With Emphasis on the In vivo and In vitro Functions of miR-190. Front Genet (2012) 0.89
Role of mu-opioid receptor in modulation of preproenkephalin mRNA expression and opioid and dopamine receptor binding in methamphetamine-sensitized mice. J Neurosci Res (2007) 0.89
In vivo activation of a mutant mu-opioid receptor by antagonist: future direction for opiate pain treatment paradigm that lacks undesirable side effects. Proc Natl Acad Sci U S A (2003) 0.89
Cholesterol regulates micro-opioid receptor-induced beta-arrestin 2 translocation to membrane lipid rafts. Mol Pharmacol (2011) 0.89
DNA methylation-related chromatin modification in the regulation of mouse delta-opioid receptor gene. Mol Pharmacol (2005) 0.89
Agonist-dependent postsynaptic effects of opioids on miniature excitatory postsynaptic currents in cultured hippocampal neurons. J Neurophysiol (2006) 0.89
Morphine induces AMPA receptor internalization in primary hippocampal neurons via calcineurin-dependent dephosphorylation of GluR1 subunits. J Neurosci (2010) 0.89
Morphine induces CD4+ T cell IL-4 expression through an adenylyl cyclase mechanism independent of the protein kinase A pathway. J Immunol (2005) 0.89
Mu-opioid receptor mediates chronic restraint stress-induced lymphocyte apoptosis. J Immunol (2002) 0.88
mu-Opioid receptor cell surface expression is regulated by its direct interaction with Ribophorin I. Mol Pharmacol (2009) 0.88
Interplay of Sps and poly(C) binding protein 1 on the mu-opioid receptor gene expression. Biochem Biophys Res Commun (2006) 0.88
Novel function of neuron-restrictive silencer factor (NRSF) for posttranscriptional regulation. Biochim Biophys Acta (2008) 0.88
A major species of mouse mu-opioid receptor mRNA and its promoter-dependent functional polyadenylation signal. Mol Pharmacol (2005) 0.88
Transcriptional regulation of mouse mu opioid receptor gene in neuronal cells by poly(ADP-ribose) polymerase-1. J Cell Mol Med (2008) 0.86
Altered emotional behaviors and the expression of 5-HT1A and M1 muscarinic receptors in micro-opioid receptor knockout mice. Synapse (2004) 0.86
Mu and delta receptors mediate morphine effects on phagocytosis by murine peritoneal macrophages. J Neuroimmunol (2003) 0.86
Differential use of an in-frame translation initiation codon regulates human mu opioid receptor (OPRM1). Cell Mol Life Sci (2009) 0.86
p38 mitogen-activated protein kinase and PI3-kinase are involved in up-regulation of mu opioid receptor transcription induced by cycloheximide. J Neurochem (2011) 0.86
Sustained activation of phosphatidylinositol 3-kinase/Akt/nuclear factor kappaB signaling mediates G protein-coupled delta-opioid receptor gene expression. J Biol Chem (2005) 0.86
uAUG-mediated translational initiations are responsible for human mu opioid receptor gene expression. J Cell Mol Med (2009) 0.85
Inhibition of akt/protein kinase B signaling by naltrindole in small cell lung cancer cells. Cancer Res (2004) 0.85
A novel signaling pathway of nitric oxide on transcriptional regulation of mouse kappa opioid receptor gene. J Neurosci (2002) 0.85
Opioid receptors: toward separation of analgesic from undesirable effects. Trends Biochem Sci (2013) 0.84
Ligand-selective activation of mu-oid receptor: demonstrated with deletion and single amino acid mutations of third intracellular loop domain. J Pharmacol Exp Ther (2003) 0.84
Regulation of mouse kappa opioid receptor gene expression by different 3'-untranslated regions and the effect of retinoic acid. Mol Pharmacol (2002) 0.84
NGF/PI3K signaling-mediated epigenetic regulation of delta opioid receptor gene expression. Biochem Biophys Res Commun (2008) 0.84
Cholesterol level influences opioid signaling in cell models and analgesia in mice and humans. J Lipid Res (2012) 0.84
Activation of protein kinase C (PKC)α or PKCε as an approach to increase morphine tolerance in respiratory depression and lethal overdose. J Pharmacol Exp Ther (2012) 0.83